First Online: 29 February 2016
: J.R.L. holds stock ownership in 23andMe, Inc. and Lasergen, Inc., is a paid consultant for Regeneron Pharmaceuticals and is a co-inventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Baylor-Miraca Medical Genetics Laboratories (BMGL;ExternalRef removed). J.R.L. is a member of the BMGL advisory board. C.M.B.C. has no competing interests.